疾病
药物开发
免疫系统
医学
药品
糖酵解
生物信息学
神经科学
药理学
癌症研究
生物
新陈代谢
内科学
免疫学
作者
Han Zhang,Jiulu Zhao,Jizhang Yu,Xi Zhang,Shuan Ran,Song Wang,Weicong Ye,Zilong Luo,Xiaohan Li,Yanglin Hao,Junjie Zong,Ran Li,Longyong Lai,Kexiao Zheng,Pinyan Huang,Zhou Cheng,Jie Wu,Li Yuan,Jiahong Xia
标识
DOI:10.3389/fcvm.2024.1489438
摘要
Cardiovascular disease (CVD) is responsible for approximately 30% of annual global mortality rates, yet existing treatments for this condition are considered less than ideal. Despite being previously overlooked, lactate, a byproduct of glycolysis, is now acknowledged for its crucial role in the cellular functions of the cardiovascular system. Recent studies have shown that lactate influences the proliferation, differentiation, and activation of immune cells through its modulation of post-translational protein modifications, thereby affecting the development and prognosis of cardiovascular disease. Consequently, there has been a notable increase in interest towards drug targets targeting lactylation in immune cells, prompting further exploration. In light of the swift advancements in this domain, this review article is dedicated to examining lactylation in cardiovascular disease and potential drug targets for regulating lactylation, with the aim of enhancing comprehension of this intricate field.
科研通智能强力驱动
Strongly Powered by AbleSci AI